IEX

IDEX Corp. 10-Q Summary: Quarter Ended September 30, 2002

Business Context and Reporting Period

This report covers the third quarter and nine months ended September 30, 2002, for IDEX Corporation, a global manufacturer of fluid handling products and specialized industrial equipment. The company operates through three segments: Pump Products, Dispensing Equipment, and Other Engineered Products. IDEX adopted SFAS No. 142 on January 1, 2002, eliminating the amortization of goodwill and intangible assets, which significantly impacts year-over-year comparisons.

Key Financial Metrics

Material Changes vs. Prior Period

• Profitability Surge: Net income increased 80% in Q3 and 48% for the nine-month period compared to 2001. This is primarily driven by the elimination of goodwill amortization (approx. $3.6M in Q3 2001) and restructuring charges ($5.7M in 9M 2001 vs. $0.1M net in 9M 2002).
• Revenue Growth: Q3 sales rose 6% year-over-year, aided by acquisitions (Rheodyne, Halox) and favorable foreign currency translation. Nine-month sales were essentially flat due to a 4% decline in base business offset by acquisition growth.
• Debt Reduction: Long-term debt decreased by approximately $42 million since year-end 2001, funded by operating cash flow and proceeds from a $50.9M common stock offering in April 2002.
• Restructuring Reversal: In June 2002, the company reversed $1.2M of accrued restructuring expenses from 2001 due to higher-than-anticipated proceeds from the sale of a manufacturing facility.

Guidance, Outlook, and Risks

Outlook: Management notes that while economic conditions have improved, order growth has been flat for the last three quarters. The company maintains a short-cycle business model with limited visibility into future conditions. However, IDEX is positioned for earnings improvement as the economy strengthens, leveraging lower cost structures from restructuring and operational excellence initiatives (Lean, Six Sigma).

Acquisitions: The company continues to pursue acquisitions to drive growth, recently acquiring Wrightech, Rheodyne, and Halox for a total of $71.5M in the first nine months.

Risks and Contingencies:

• Asbestos Litigation: IDEX and five subsidiaries are defendants in asbestos-related lawsuits. While costs have historically been covered by insurance, the company cannot predict future insurance availability or claim outcomes.
• Market Conditions: Results are sensitive to industrial activity, capital spending, and foreign currency exchange rates (specifically the Euro and British Pound).
• Goodwill Impairment: Under SFAS 142, goodwill is no longer amortized but tested for impairment. No impairment was recorded as of September 30, 2002, but future economic downturns could trigger non-cash charges.

Investor Verification Checklist

• Adjusted EPS Comparison: Verify the impact of the accounting change (SFAS 142) by comparing reported 2002 EPS against 2001 EPS adjusted for the removal of goodwill amortization.
• Base Business Trends: Confirm the 4% decline in base business sales for the nine-month period to assess organic growth challenges.
• Debt Covenants: Review the credit facility covenant limiting total debt to three times operating cash flow (limit was $378M at period end).
• Restructuring Accruals: Monitor the utilization of the remaining $1.9M restructuring accrual, expected to be fully utilized by year-end 2002.
• Acquisition Integration: Assess the contribution of recent acquisitions (Rheodyne, Halox, Wrightech) to future revenue streams.